Evidence map›Paper›PMID 29632723›Full record

ArticleOncoimmunology

Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells.

Friedrich Foerster, Sebastian Boegel, Rosario Heck, Geetha Pickert, Nina Rüssel, Sebastian Rosigkeit, Matthias Bros, Stephanie Strobl, Leonard Kaps, Misbah Aslam and 6 more

Abstract read
In one paragraph

Article in Oncoimmunology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. pH-degradable, bisphosphonate-loaded nanogels attenuate liver fibrosis by repolarization of M2-type macrophages.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  11. MITF induces escape from innate immunity in melanoma.Journal of experimental & clinical cancer research : CR · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Exposition to Biological Control AgentFrontiers in cellular and infection microbiology · 2020
    Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Friedrich FoersterFirst Department of Medicine, University Medical Center Mainz, Mainz, Germany.
Sebastian BoegelTRON - Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Mainz, Germany.
Rosario HeckInstitute of Translational Immunology and Research Center for Immunotherapy, University Medical Center Mainz, Mainz, Germany.
Geetha PickertInstitute of Translational Immunology and Research Center for Immunotherapy, University Medical Center Mainz, Mainz, Germany.
Nina RüsselInstitute of Translational Immunology and Research Center for Immunotherapy, University Medical Center Mainz, Mainz, Germany.
Sebastian RosigkeitInstitute of Translational Immunology and Research Center for Immunotherapy, University Medical Center Mainz, Mainz, Germany.
Matthias BrosDepartment of Dermatology, University Medical Center Mainz, Mainz, Germany.
Stephanie StroblInstitute of Translational Immunology and Research Center for Immunotherapy, University Medical Center Mainz, Mainz, Germany.
Leonard KapsInstitute of Translational Immunology and Research Center for Immunotherapy, University Medical Center Mainz, Mainz, Germany.
Misbah AslamInstitute of Translational Immunology and Research Center for Immunotherapy, University Medical Center Mainz, Mainz, Germany.
Mustafa DikenTRON - Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Mainz, Germany.
John CastleTRON - Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Mainz, Germany.
Ugur SahinTRON - Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Mainz, Germany.
Andrea TuettenbergDepartment of Dermatology, University Medical Center Mainz, Mainz, Germany.
Ernesto BockampInstitute of Translational Immunology and Research Center for Immunotherapy, University Medical Center Mainz, Mainz, Germany.
Detlef SchuppanInstitute of Translational Immunology and Research Center for Immunotherapy, University Medical Center Mainz, Mainz, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The B16F10 murine melanoma cell line displays a low expression of MHC class I molecules favoring immune evasion and metastases in immunocompetent C57 BL/6 wild-type mice. Here, we generated metastases to the liver, an organ that is skewed towards immune tolerance, by intrasplenic injection of B16F10 cells in syngeneic C57 BL/6 compared to allogeneic Balb/c mice. Surprisingly, Balb/c mice, which usually display a pronounced M2 macrophage and Th2 T cell polarization, were ∼3 times more susceptible to metastasis than C57 BL/6 mice, despite a much higher M1 and Th1 T cell immune response. The anti-metastatic advantage of C57 BL/6 mice could be attributed to a more potent NK-cell mediated cytotoxicity against B16F10 cells. Our findings highlight the role of NK cells in innate anti-tumor immunity in the context of the liver - particularly against highly aggressive MHC I-deficient cancer cells. Moreover, the B16F10 model of melanoma liver metastasis is suited for developing novel therapies targeting innate NK cell related immunity in liver metastases and liver cancer.

Indexed as

cancer immunologyinnate immunitylivermacrophagesmetastasisNK cells

Identifiers

PMID29632723
PMCPMC5889278

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.